Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs
Authors:
- Sophie ValentinSVSophie Valentin
- Benoit RemyBRBenoit Remy
- Pascale JespersPJPascale Jespers
- Suzanne FoulonSFSuzanne Foulon
- Nicole Van IsraëlNINicole Van Israël
- Cécile ClercxCCCécile Clercx
- Kathleen McEnteeKMKathleen McEntee
- 1 May 2006
- journal article
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 67 (5) , 749-755
Abstract
Objective —To validate a radioimmunoassay for measurement of procollagen type III amino terminal propeptide (PIIINP) concentrations in canine serum and bronchoalveolar lavage fluid (BALF) and investigate the effects of physiologic and pathologic conditions on PIIINP concentrations. Sample Population —Sera from healthy adult (n = 70) and growing dogs (20) and dogs with chronic renal failure (CRF; 10), cardiomyopathy (CMP; 12), or degenerative valve disease (DVD; 26); and sera and BALF from dogs with chronic bronchopneumopathy (CBP; 15) and healthy control dogs (10 growing and 9 adult dogs). Procedure —A radioimmunoassay was validated, and a reference range for serum PIIINP (S-PIIINP) concentration was established. Effects of growth, age, sex, weight, CRF, and heart failure on S-PIIINP concentration were analyzed. In CBP-affected dogs, S-PIIINP and BALF-PIIINP concentrations were evaluated. Results —The radioimmunoassay had good sensitivity, linearity, precision, and reproducibility and reasonable accuracy for measurement of S-PIIINP and BALF-PIIINP concentrations. The S-PIIINP concentration reference range in adult dogs was 8.86 to 11.48 μg/L. Serum PIIINP concentration correlated with weight and age. Growing dogs had significantly higher S-PIIINP concentrations than adults, but concentrations in CRF-, CMP-, DVD-, or CBP-affected dogs were not significantly different from control values. Mean BALF-PIIINP concentration was significantly higher in CBP-affected dogs than in healthy adults. Conclusions and Clinical Relevance —In dogs, renal or cardiac disease or CBP did not significantly affect S-PIIINP concentration; dogs with CBP had high BALF-PIIINP concentrations. Data suggest that the use of PIIINP as a marker of pathologic fibrosis might be limited in growing dogs.Keywords
This publication has 30 references indexed in Scilit:
- Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipientsTransplantation, 2003
- Collagenolytic Activity in Bronchoalveolar Lavage Fluid in Canine Pulmonary EosinophiliaJournal of Veterinary Internal Medicine, 2002
- An Immunologic Investigation of Canine Eosinophilic BronchopneumopathyJournal of Veterinary Internal Medicine, 2002
- Treatment of Congestive Heart FailureHypertension, 2001
- Eosinophilic Bronchopneumopathy in DogsJournal of Veterinary Internal Medicine, 2000
- Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosisThe American Journal of Cardiology, 1995
- Biochemical and hormonal changes induced by one week of administration of rIGF‐I to patients with Laron type dwarfismClinical Endocrinology, 1991
- Serum Hyaluronic Acid and Procollagen III Amino Terminal Propeptide in Chronic Renal FailureAmerican Journal of Nephrology, 1991
- Increased Procollagen III Production in Patients with Kidney DiseaseNephron, 1988
- Biosynthesis of ProcollagenAnnual Review of Biochemistry, 1978